JAK inhibitor Ruxolitinib sulfate, Purity ≥98%

Synonym: Ruxolitinib sulfate; 1092939-16-6; INCB018424 sulfate; beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(betaR)-1H-pyrazole-1-propanenitrile, (2Z)-2-butenedioate); BCP27733; FT-0770538; JAK inhibitor

CAS Number: 1092939-16-6
Compound CID: 74388974

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Ruxolitinib sulfate is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, and Tyk2.

Molecular Weight

404.44

Molecular Formula

C₁₇H₂₀N₆O₄S

Targets

JAK1: 3.3 nM; JAK2: 2.8 nM; JAK3: 428 nM; Tyk2: 19 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Ruxolitinib sulfate can be applied to research the selective inhibition of JAK1 and JAK2.

Storage

Store at -20ºC.